235
Views
15
CrossRef citations to date
0
Altmetric
Original Article

3-Hydroxy-3-methylglutaric and 3-methylglutaric acids impair redox status and energy production and transfer in rat heart: relevance for the pathophysiology of cardiac dysfunction in 3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency

, , , , , & show all
Pages 997-1010 | Received 26 Jan 2016, Accepted 16 Jul 2016, Published online: 23 Aug 2016

References

  • Sweetman L, Williams JC. Branched chain organic acidurias. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease. 8th ed. New York: McGraw-Hill; 2001: 2340–2342.
  • Ozand PT, al Aqeel A, Gascon G, Brismar J, Thomas E, Gleispach H. 3-Hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) lyase deficiency in Saudi Arabia. J Inherit Metab Dis 1991;14:174–188.
  • Puisac B, Arnedo M, Casale CH, Ribate MP, Castiella T, Ramos FJ, et al. Differential HMG-CoA lyase expression in human tissues provides clues about 3-hydroxy-3-methylglutaric aciduria. J Inherit Metab Dis 2010;33:405–410.
  • Gibson KM, Cassidy SB, Seaver LH, Wanders RJ, Mitchell GA, Spark RP. Fatal cardiomyopathy associated with 3-hydroxy-3-methylglutaryl-CoA lyase deficiency. J Inherit Metab Dis 1994;17:291–294.
  • Ruesch S, Krähenbühl S, Kleinle S, Liechti-Gallati S, Schaffner T, Wermuth B, et al. Combined 3-methylglutaconic and 3-hydroxy-3-methylglutaric aciduria with endocardial fibroelastosis and dilatative cardiomyopathy in male and female siblings with partial deficiency of complex II/III in fibroblasts. Enzyme Protein 1996;49:321–329.
  • Dasouki M, Buchanan D, Mercer N, Gibson KM, Thoene J. 3-Hydroxy-3 methylglutaric aciduria: response to carnitine therapy and fat and leucine restriction. J Inherit Metab Dis 1987;10:142–146.
  • Leung AA, Chan AK, Ezekowitz JA, Leung AK. A case of dilated cardiomyopathy associated with 3-hydroxy-3-methylglutaryl-coenzyme A (HMG CoA) lyase deficiency. Case Rep Med 2009;2009:183125.
  • Leipnitz G, Seminotti B, Haubrich J, Dalcin KB, Solano A, de Bortoli G, et al. Evidence that 3-hydroxy-3-methylglutaric acid promotes lipid and protein oxidative damage and reduces the nonenzymatic antioxidant defenses in rat cerebral cortex. J Neurosci Res 2008a;86:683–693.
  • Leipnitz G, Seminotti B, Amaral AU, de Bortoli G, Solano A, Schuck PF, et al. Induction of oxidative stress by the metabolites accumulating in 3-methylglutaconic aciduria in cerebral cortex of young rats. Life Sci 2008b;82:652–662.
  • Fernandes CG, da Rosa MS, Seminotti B, Pierozan P, Martell RW, Lagranha VL, et al. In vivo experimental evidence that the major metabolites accumulating in 3-hydroxy-3-methylglutaryl-CoA lyase deficiency induce oxidative stress in striatum of developing rats: a potential pathophysiological mechanism of striatal damage in this disorder. Mol Genet Metab 2013;109:144–153.
  • da Rosa MS, Seminotti B, Amaral AU, Fernandes CG, Gasparotto J, Moreira JC, et al. Redox homeostasis is compromised in vivo by the metabolites accumulating in 3-hydroxy-3-methylglutaryl-CoA lyase deficiency in rat cerebral cortex and liver. Free Radic Res 2013;47:1066–1075.
  • Grings M, Moura AP, Parmeggiani B, Marcowich GF, Amaral AU, de Souza Wyse AT, et al. Disturbance of brain energy and redox homeostasis provoked by sulfite and thiosulfate: potential pathomechanisms involved in the neuropathology of sulfite oxidase deficiency. Gene 2013;531:191–198.
  • Jiang S, Zhu W, Wu J, Li C, Zhang X, Li Y, et al. α-Lipoic acid protected cardiomyoblasts from the injury induced by sodium nitroprusside through ROS-mediated Akt/Gsk-3β activation. Toxicol In Vitro 2014;28:1461–1473.
  • Mesquita Casagrande AC, Wamser MN, de Lima DD, Pereira da Cruz JG, Wyse AT, Dal Magro DD. In vitro stimulation of oxidative stress by hypoxanthine in blood of rats: prevention by vitamins e plus C and allopurinol. Nucleosides Nucleotides Nucleic Acids 2013;32:42–57.
  • Li X, Lu J, Shang P, Bao J, Yue Z. The selective NADPH oxidase inhibitor apocynin has potential prophylactic effects on melamine-related nephrolithiasis in vitro and in vivo. Mol Cell Biochem 2015;399:167–78.
  • Evelson P, Travacio M, Repetto M, Escobar J, Llesuy S, Lissi EA. Evaluation of total reactive antioxidant potential (TRAP) of tissue homogenates and their cytosols. Arch Biochem Biophys 2001;388:261–266.
  • Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72: 248–254.
  • Fischer JC, Ruitenbeek W, Berden JA, Trijbels JM, Veerkamp JH, Stadhouders AM, et al. Differential investigation of the capacity of succinate oxidation in human skeletal muscle. Clin Chim Acta1985;153:23–36.
  • Schapira AH, Mann VM, Cooper JM, Dexter D, Daniel SE, Jenner P, et al. Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease. J Neurochem 1990;55:2142–2145.
  • da Silva CG, Ribeiro CA, Leipnitz G, Dutra-Filho CS, Wyse AT, Wannmacher CM, et al. Inhibition of cytochrome c oxidase activity in rat cerebral cortex and human skeletal muscle by D-2-hydroxyglutaric acid in vitro. Biochim Biophys Acta 2002;1586:81–91.
  • Hughes BP. A method for the estimation of serum creatine kinase and its use in comparing creatine kinase and aldolase activity in normal and pathological sera. Clin Chim Acta 1962;7:597–603.
  • da Silva CG, Bueno AR, Schuck PF, Leipnitz G, Ribeiro CA, Rosa RB, et al. Inhibition of creatine kinase activity from rat cerebral cortex by D-2-hydroxyglutaric acid in vitro. Neurochem Int 2004;44:45–52.
  • Dikalov S, Griendling KK, Harrison DG. Measurement of reactive oxygen species in cardiovascular studies. Hypertension 2007;49:717–727.
  • Wagner C, Vargas AP, Roos DH, Morel AF, Farina M, Nogueira CW, et al. Comparative study of quercetin and its two glycoside derivatives quercitrin and rutin against methylmercury (MeHg)-induced ROS production in rat brain slices. Arch Toxicol 2010;84:89–97.
  • Reznick AZ, Packer L. Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Meth Enzymol 1994;233:357–363.
  • Yagi K. Simple procedure for specific assay of lipid hydroperoxides in serum or plasma. Methods Mol Biol 1998;108:107–110.
  • Browne RW, Armstrong D. Reduced glutathione and glutathione disulfide. Methods Mol Biol 1998;108:347–352.
  • Wendel A. Glutathione peroxidase. Meth Enzymol 1981;77:325–332.
  • Calberg I, Mannervik B. Glutathione reductase. Meth Enzymol 1985;113:484–490.
  • Habig WH, Pabst MJ, Jacoby WB. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 1974;249:7130–7139.
  • Marklund SL. Pyrogallol autoxidation. Handbook for oxygen radical research. Boca Raton: CRC Press; 1985: 243–247.
  • Aebi H. Catalase in vitro. Meth Enzymol 1984;105:121–126.
  • Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265–275.
  • Funghini S, Pasquini E, Cappellini M, Donati MA, Morrone A, Fonda C, Zammarchi E. 3-Hydroxy-3-methylglutaric aciduria in an Italian patient is caused by a new nonsense mutation in the HMGCL gene. Mol Genet Metab 2001;73:268–275.
  • Vargas CR, Sitta A, Schmitt G, Ferreira GC, Cardoso ML, Coelho D, et al. Incidence of 3-hydroxy-3-methylglutaryl-CoA coenzyme A lyase (HL) deficiency in Brazil, South America. J Inherit Metab Dis 2007;3:511–515.
  • Zafeiriou DI, Vargiami E, Mayapetek E, Augoustidou-Sawopoulou P, Mitchell GA. 3-Hydroxy-3-methylglutaryl coenzyme a lyase deficiency with reversible white matter changes after treatment. Pediatr Neurol 2007;37:47–50.
  • Wendt S, Schlattner U, Wallimann T. Differential effects of peroxynitrite on human mitochondrial creatine kinase isoenzymes. Inactivation, octamer destabilization, and identification of involved residues. J Biol Chem 2003;278:1125–1130.
  • Rosca MG, Hoppel CL. Mitochondrial dysfunction in heart failure. Heart Fail Rev 2013;18:607–622.
  • Du F, Cooper A, Lukas SE, Cohen BM, Ongur D. Creatine kinase and ATP synthase reaction rates in human frontal lobe measured by 31P magnetization transfer spectroscopy at 4T. Magn Reson Imaging 2013;31:102–108.
  • Li C, Sun S, Park D, Jeong HO, Chung HY, Liu XX, Zhou HM. Hydrogen peroxide targets the cysteine at the active site and irreversibly inactivates creatine kinase. Int J Biol Macromol 2011;49:910–916.
  • Wang PF, McLeish MJ, Kneen MM, Lee G, Kenyon GL. An unusually low pK(a) for Cys282 in the active site of human muscle creatine kinase. Biochemistry 2001;40:11698–11705.
  • Arstall MA, Bailey C, Gross WL, Bak M, Balligand JL, Kelly RA. Reversible S-nitrosation of creatine kinase by nitric oxide in adult rat ventricular myocytes. J Mol Cell Cardiol 1998;30:979–988.
  • Konorev EA, Hogg N, Kalyanaraman B. Rapid and irreversible inhibition of creatine kinase by peroxynitrite. FEBS Lett 1998;427:171–174.
  • Stachowiak O, Schlattner U, Dolder M, Wallimann T. Oligomeric state and membrane binding behaviour of creatine kinase isoenzymes: implications for cellular function and mitochondrial structure. Mol Cell Biochem 1998;184:141–151.
  • Wallimann T, Dolder M, Schlattner U, Eder M, Hornemann T, Kraft T, Stolz M. Creatine kinase: an enzyme with a central role in cellular energy metabolism. MAGMA 1998;6:116–119.
  • Dalle-Done I, Rossi R, Giustarini D, Milzani A, Colombo R. Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta 2003;329:23–38.
  • Sarafian TA, Bredesen DE, Verity MA. Cellular resistance to methylmercury. Neurotoxicology 1996;17:27–36.
  • Rushmore TH, Morton MR, Pickett CB. The antioxidant responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity. J Biol Chem 1991;266:11632–11639.
  • Lakshminarayanan V, Drab-Weiss EA, Roebuck KA, H2O2 and tumor necrosis factor-alpha induce differential binding of the redox-responsive transcription factors AP-1 and NF-kappaB to the interleukin-8 promoter in endothelial and epithelial cells. J Biol Chem 1998;273:32670–32678.
  • Halliwell B. Oxidative stress and neurodegeneration: where are we now? J Neurochem 2006;97:1634–1658.
  • McMahon M, Itoh K, Yamamoto M, Chanas SA, Henderson CJ, McLellan LI, et al. The cap‘n’collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes. Cancer Res 2001;61:3299–3307.
  • Alvarez B, Demicheli V, Durán R, Trujillo M, Cerveñansky C, Freeman BA, Radi R. Inactivation of human Cu,Zn superoxide dismutase by peroxynitrite and formation of histidinyl radical. Free Radic Biol Med 2004;37:813–822.
  • Uchida K, Kawakishi S. Identification of oxidized histidine generated at the active site of Cu,Zn-superoxide dismutase exposed to H2O2: selective generation of 2-oxo-histidine at the histidine 118. J Biol Chem 1994;269:2405–2410.
  • Escobar JA, Rubio A, Lissi EA. SOD and catalase inactivation by singlet oxygen and peroxyl radicals. Free Radic Biol Med 1996;20:285–290.
  • Kim YK, Kwon OJ, Park JW. Inactivation of catalase and superoxide dismutase by singlet oxygen derived from photoactivated dye. Biochimie 2001;83:437–444.
  • Mapanga RF, Rajamani U, Dlamini N, Zungu-Edmondson M, Kelly-Laubscher R, Shafiullah M, et al. Oleanolic acid: a novel cardioprotective agent that blunts hyperglycemia-induced contractile dysfunction. PLoS One 2012;7:e47322.
  • Adams B, Mapanga RF, Essop MF. Partial inhibition of the ubiquitin-proteasome system ameliorates cardiac dysfunction following ischemia-reperfusion in the presence of high glucose. Cardiovasc Diabetol 2015;14:94.
  • Bhat M, Ismail A. Vitamin D treatment protects against and reverses oxidative stress induced muscle proteolysis. J Steroid Biochem Mol Biol 2015;152:171–179.
  • Cervellati C, Sticozzi C, Romani A, Belmonte G, De Rasmo D, Signorile A, Cervellati F, et al. Impaired enzymatic defensive activity, mitochondrial dysfunction and proteasome activation are involved in RTT cell oxidative damage. Biochim Biophys Acta 2015;1852:2066–2074.
  • Rodriguez C, Mayo JC, Sainz RM, Antolín I, Herrera F, Martín V, Reiter RJ. Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res. 2004;36:1–9.
  • Sauer SW, Okun JG, Fricker G, Mahringer A, Müller I, Crnic LR, et al. Intracerebral accumulation of glutaric and 3-hydroxyglutaric acids secondary to limited flux across the blood-brain barrier constitute a biochemical risk factor for neurodegeneration in glutaryl-CoA dehydrogenase deficiency. J Neurochem 2006;97:899–910.
  • Halliwell B, Gutteridge JMC. Measurement of reactive species. In: Halliwell B, Gutteridge JMC, eds. Free radicals in biology and medicine. 4th ed. Oxford: Oxford University Press; 2007: 268–340.
  • Paramar P, Limson J, Nyokong T, Daya S. Melatonin protects against copper-mediated free radical damage. J Pineal Res 2002;32:237–242.
  • García JJ, López-Pingarrón L, Almeida-Souza P, Tres A, Escudero P, García-Gil FA, et al. Protective effects of melatonin in reducing oxidative stress and in preserving the fluidity of biological membranes: a review. J Pineal Res 2014;56:225–237.
  • Karaaslan C, Suzen S. Antioxidant properties of melatonin and its potential action in diseases. Curr Top Med Chem 2015;15:894–903.
  • Bonnefont-Rousselot D, Collin F. Melatonin: action as antioxidant and potential applications in human disease and aging. Toxicology 2010;278:55–67.
  • Moura FA, de Andrade KQ, dos Santos JC, Goulart MO. Lipoic acid: its antioxidant and anti-inflammatory role and clinical applications. Curr Top Med Chem 2015;15:458–483.
  • Packer L, Witt EH, Tritschler HJ. alpha-Lipoic acid as a biological antioxidant. Free Radic Biol Med 1995;19:227–50.
  • Skibska B, Goraca A. The protective effect of lipoic acid on selected cardiovascular diseases caused by age-related oxidative stress. Oxid Med Cell Longev 2015;2015:313021.
  • Paradies G, Paradies V, Ruggiero FM, Petrosillo G. Protective role of melatonin in mitochondrial dysfunction and related disorders. Arch Toxicol 2015;89:923–939.
  • Hirata Y, Ishii K, Taguchi T, Suita S, Takeshige K. Conversion of xanthine dehydrogenase to xanthine oxidase during ischemia of the rat small intestine and the effect of trifluoperazine on the conversion. J Pediatr Surg 1993;28:597–600.
  • McNally JS, Saxena A, Cai H, Dikalov S, Harrison DG. Regulation of xanthine oxidoreductase protein expression by hydrogen peroxide and calcium. Arterioscler Thromb Vasc Biol 2005;25:1623–1628.
  • Zhang Y, Hu S, Chen Y. Hepatocyte growth factor suppresses hypoxia/reoxygenation-induced XO activation in cardiac microvascular endothelial cells. Heart Vessels 2015;30:534–544.
  • Zhang Y, Zhou H, Wu W, Shi C, Hu S, Yin T, et al. Liraglutide protects cardiac microvascular endothelial cells against hypoxia/reoxygenation injury through the suppression of the SR-Ca(2+)-XO-ROS axis via activation of the GLP-1R/PI3K/Akt/survivin pathways. Free Radic Biol Med 2016;95:278–292.
  • Abeti R, Abramov AY. Mitochondrial Ca(2+) in neurodegenerative disorders. Pharmacol Res 2015;99:377–381.
  • Joshi AU, Kornfeld OS, Mochly-Rosen D. The entangled ER-mitochondrial axis as a potential therapeutic strategy in neurodegeneration: a tangled duo unchained. Cell Calcium 2016, Article in press.
  • Ishii T, Yasuda K, Akatsuka A, Hino O, Hartman PS, Ishii N. A mutation in the SDHC gene of complex II increases oxidative stress, resulting in apoptosis and tumorigenesis. Cancer Res 2005;65:203–209.
  • Slane BG, Aykin-Burns N, Smith BJ, Kalen AL, Goswami PC, Domann FE, Spitz DR. Mutation of succinate dehydrogenase subunit C results in increased O2.-, oxidative stress, and genomic instability. Cancer Res 2006;66:7615–7620.
  • Liu Y, Barber DS, Zhang P, Liu B. Complex II of the mitochondrial respiratory chain is the key mediator of divalent manganese-induced hydrogen peroxide production in microglia. Toxicol Sci 2013;132:298–306.
  • Atkuri KR, Cowan TM, Kwan T, Ng A, Herzenberg LA, Herzenberg LA, Enns GM. Inherited disorders affecting mitochondrial function are associated with glutathione deficiency and hypocitrullinemia. Proc Natl Acad Sci USA 2009;106:3941–3945.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.